Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier in life, a study suggests. The research team, led by Michigan Medicine, ...